Rekah Pharmaceutical Industry Balance Sheet Health
Financial Health criteria checks 4/6
Rekah Pharmaceutical Industry has a total shareholder equity of ₪155.6M and total debt of ₪140.1M, which brings its debt-to-equity ratio to 90.1%. Its total assets and total liabilities are ₪484.7M and ₪329.1M respectively. Rekah Pharmaceutical Industry's EBIT is ₪2.9M making its interest coverage ratio 0.4. It has cash and short-term investments of ₪19.3M.
Key information
90.1%
Debt to equity ratio
₪140.14m
Debt
| Interest coverage ratio | 0.4x |
| Cash | ₪19.35m |
| Equity | ₪155.59m |
| Total liabilities | ₪329.14m |
| Total assets | ₪484.72m |
Recent financial health updates
Rekah Pharmaceutical Industry (TLV:REKA) Has A Somewhat Strained Balance Sheet
Sep 12
We Think Rekah Pharmaceutical Industry (TLV:REKA) Is Taking Some Risk With Its Debt
May 12Is Rekah Pharmaceutical Industry (TLV:REKA) Using Too Much Debt?
Jan 29Recent updates
Here's Why Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) CEO May Not Expect A Pay Rise This Year
Dec 14Rekah Pharmaceutical Industry (TLV:REKA) Has A Somewhat Strained Balance Sheet
Sep 12Estimating The Fair Value Of Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Jul 19Rekah Pharmaceutical Industry's (TLV:REKA) Problems Go Beyond Weak Profit
Apr 13We Think Rekah Pharmaceutical Industry (TLV:REKA) Is Taking Some Risk With Its Debt
May 12Here's Why I Think Rekah Pharmaceutical Industry (TLV:REKA) Might Deserve Your Attention Today
Apr 09Does Rekah Pharmaceutical Industry's (TLV:REKA) Share Price Gain of 50% Match Its Business Performance?
Mar 12Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 19
Is Rekah Pharmaceutical Industry (TLV:REKA) Using Too Much Debt?
Jan 29Here's Why I Think Rekah Pharmaceutical Industry (TLV:REKA) Is An Interesting Stock
Jan 08How Is Rekah Pharmaceutical Industry's (TLV:REKA) CEO Paid Relative To Peers?
Dec 18Investors Who Bought Rekah Pharmaceutical Industry (TLV:REKA) Shares Five Years Ago Are Now Up 33%
Nov 30Financial Position Analysis
Short Term Liabilities: REKA's short term assets (₪251.3M) exceed its short term liabilities (₪143.8M).
Long Term Liabilities: REKA's short term assets (₪251.3M) exceed its long term liabilities (₪185.4M).
Debt to Equity History and Analysis
Debt Level: REKA's net debt to equity ratio (77.6%) is considered high.
Reducing Debt: REKA's debt to equity ratio has increased from 55.9% to 90.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable REKA has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: REKA is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 36% per year.